Mohamad, Aimi Fadilah, et al. “RISK OF KETOACIDOSIS WITH LUSEOGLIFLOZIN IN TYPE 2 DIABETES MELLITUS PATIENTS ON MODERATE DOSE INSULIN THERAPY: A RANDOMISED CONTROL TRIAL”. Journal of the ASEAN Federation of Endocrine Societies, vol. 39, no. S1, July 2024, pp. 34-35, doi:10.15605/jafes.039.S1.053.